Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.59 |
| ▸ | ACHE | P22303 | 2/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | ELANE | P08246 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3828627 | 0.84 | LMNA (0.58) | LMNACYP3A4ACHEKMT2AMEN1 | |
| SCHEMBL10547627 | 0.84 | CYP3A4 (0.58) | LMNACYP3A4ACHEKMT2AMEN1 | |
| SCHEMBL16953007 | 0.84 | LMNA (0.58) | LMNACYP3A4ACHEKMT2AMEN1 | |
| SCHEMBL30676498 | 0.84 | CYP3A4 (0.58) | LMNACYP3A4ACHEKMT2AMEN1 | |
| SCHEMBL15611000 | 0.82 | CYP3A4 (0.56) | LMNACYP3A4ACHEKMT2AMEN1 | |
| SCHEMBL249305 | 0.82 | LMNA (0.76) | LMNACYP3A4ACHEKMT2AMEN1 | |
| SCHEMBL17028900 | 0.82 | LMNA (0.76) | LMNACYP3A4ACHEKMT2AMEN1 | |
| SCHEMBL7677883 | 0.81 | ACHE (0.58) | LMNAACHEKMT2AMEN1ALDH1A1 | |
| SCHEMBL7282741 | 0.80 | LMNA (0.47) | LMNACYP3A4ACHEKMT2AMEN1 | |
| SCHEMBL6829778 | 0.80 | LMNA (0.43) | LMNACYP3A4ACHEKMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230391828-A1 | REGULATORS OF CELL DIVISION | TECHNISCHE UNIVERSITAT DRESDEN (DE) | 2023-12-07 | — | — | US | claimed |
| EP-4225780-A2 | REGULATORS OF CELL DIVISION | Technische Universität Dresden (DE) | 2023-08-16 | — | — | EP | claimed |
| WO-2022074072-A2 | REGULATORS OF CELL DIVISION | Technische Universität Dresden (DE) | 2022-04-14 | — | — | WO | claimed |
| CN-110305142-B | Stereoselective synthesis method of 6 beta-hydroxymorphine derivative | 宜昌人福药业有限责任公司 | 2021-11-16 | — | — | CN | claimed |
| US-6380197-B1 | FOR TREATING AND PREVENTING A PLETHORA OF DISEASES INCLUDING DIABETES | AVENTIS PHARMA S. A. (FR) | 2002-04-30 | — | — | US | claimed |
| EP-1001943-A1 | POLYHYDROXYALKYLPYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM | Aventis Pharma S.A. (FR) | 2000-05-24 | — | — | EP | claimed |
| WO-1999003843-A1 | POLYHYDROXYALKYLPYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM | RHONE-POULENC RORER S.A. (FR) | 1999-01-28 | — | — | WO | claimed |
| CN-118139839-A | Process for producing fluorinated polyether | 株式会社力森诺科 | 2024-06-04 | — | — | CN | disclosed |
| CN-118055920-A | Process for producing fluorinated polyether | 株式会社力森诺科 | 2024-05-17 | — | — | CN | disclosed |
| US-20230391828-A1 | REGULATORS OF CELL DIVISION | TECHNISCHE UNIVERSITAT DRESDEN (DE) | 2023-12-07 | — | — | US | disclosed |
| EP-4225780-A2 | REGULATORS OF CELL DIVISION | Technische Universität Dresden (DE) | 2023-08-16 | — | — | EP | disclosed |
| WO-2022074072-A2 | REGULATORS OF CELL DIVISION | Technische Universität Dresden (DE) | 2022-04-14 | — | — | WO | disclosed |
| CN-110305142-B | Stereoselective synthesis method of 6 beta-hydroxymorphine derivative | 宜昌人福药业有限责任公司 | 2021-11-16 | — | — | CN | disclosed |
| US-4566901-A | PLANT SAFENING AGENTS | CIBA-GEIGY CORPORATION (US) | 1986-01-28 | — | — | US | disclosed |
| EP-0094348-B1 | OXIME ETHERS, PROCESS FOR THEIR PREPARATION, AGENTS CONTAINING THE OXIME ETHERS AND THEIR USE | CIBA-GEIGY AG (CH) | 1985-07-24 | — | — | EP | disclosed |
| US-4518596-A | Antithrombotic use of 2-(perhydro-1,4-diazino)-pyrimido (5,4,D)-pyrimidines | DR. KARL THOMAE GMBH (DE) | 1985-05-21 | — | — | US | disclosed |
| US-4438277-A | Hydronaphthalene derivatives | SANKYO COMPANY, LIMITED (JP) | 1984-03-20 | — | — | US | disclosed |
| EP-0094348-A1 | Oxime ethers, process for their preparation, agents containing the oxime ethers and their use | CIBA-GEIGY AG (CH) | 1983-11-16 | — | — | EP | disclosed |
| US-4415572-A | CARDIOTONIC AND INOTROPIC AGENTS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1983-11-15 | — | — | US | disclosed |
| US-4361515-A | Antihyperlipemic dihydro-ML-236B derivatives, their preparation and use | SANKYO COMPANY, LIMITED (JP) | 1982-11-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230391828-A1 | REGULATORS OF CELL DIVISION | PCNA, BOD1L1, MKI67 | LMNA 2194/4885CYP3A4 4883/4885ACHE 4884/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.